Immunomodulatory treatment of relapsing-remitting multiple sclerosis - the ASSET (Avonex Assessment in Multiple Sclerosis Therapy) study, an observational study in 1354 patients

被引：0
|
作者：
Marziniak, M.
Graf, T.
Niemczyk, G.
Rehberg-Weber, K.
机构：
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [31] Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study
    Lus, G.
    Signoriello, E.
    Maniscalco, G. T.
    Bonavita, S.
    Signoriello, S.
    Gallo, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (03) : 489 - 493
  • [32] Final analysis of combination therapy (Provigil® plus Avonex®) in the treatment of cognitive problems in patients with relapsing-remitting multiple sclerosis
    Wilken, J. A.
    Wallin, M. T.
    Sullivan, C. L.
    Kane, R. L.
    Rossman, H.
    Lawson, S.
    Simsarian, J.
    Saunders, C.
    Shin, R.
    Mikszewski, J.
    Kerr, D.
    Quig, M. E.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S114 - S114
  • [33] The effects of immunomodulatory treatments on the progression of relapsing-remitting multiple sclerosis
    Candan, E
    Yilmaz, Z
    Canturk, IA
    Isik, N
    Yildiz, N
    Seleker, T
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S234 - S235
  • [34] Circuit class therapy in patients with relapsing-remitting multiple sclerosis
    Kolcava, J.
    Kocica, J.
    Musilova, M.
    Dosbaba, F.
    Kratochvilova, J.
    Krizova, D.
    Stourac, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 633 - 634
  • [35] Effectiveness of cladribine tablets in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
    Habek, M.
    Brecl, G. Jakob
    Rajda, C.
    Adamec, I.
    Barun, B.
    Rok, A.
    Ledinek, A. Horvat
    Rot, U.
    Jazbec, S. Sega
    Gabelic, T.
    Klivenyi, P.
    Skoric, M. Krbot
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 894 - 894
  • [36] Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
    Brecl Jakob, Gregor
    Barun, Barbara
    Gomezelj, Sarah
    Gabelic, Tereza
    Sega Jazbec, Sasa
    Adamec, Ivan
    Horvat Ledinek, Alenka
    Rot, Uros
    Krbot Skoric, Magdalena
    Habek, Mario
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4591 - 4597
  • [37] Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis The MIRROR study
    Bar-Or, Amit
    Grove, Richard A.
    Austin, Daren J.
    Tolson, Jerry M.
    VanMeter, Susan A.
    Lewis, Eric W.
    Derosier, Frederick J.
    Lopez, Monica C.
    Kavanagh, Sarah T.
    Miller, Aaron E.
    Sorensen, Per S.
    [J]. NEUROLOGY, 2018, 90 (20) : E1805 - E1814
  • [38] A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate
    Moreau, T.
    Brudon, F.
    Debouverie, M.
    Heinzlef, O.
    Lebrun-Frenay, C.
    Gury, C.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
  • [39] Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
    Cocco, E.
    Marchi, P.
    Sardu, C.
    Russo, P.
    Paolillo, A.
    Mascia, M. G.
    Solla, M.
    Frau, J.
    Lorefice, L.
    Massole, S.
    Floris, G.
    Marrosu, M. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (08) : 975 - 980
  • [40] The relationship between smoking and disease activity in patients with relapsing-remitting multiple sclerosis on immunomodulatory therapy
    Rakoca, Michal
    Tywoniuk, Anna
    Adamczyk-Sowa, Monika
    Kulakowska, Alina
    Koziarska, Dorota
    Kubicka-Baczyk, Katarzyna
    Jakubowicz-Lachowska, Dominika
    Wawrzyniak, Slawomir
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2020, 20 (01): : 9 - 13
12345